|
|||||
|
|
Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement |
|
| Authors: | Martina Pigazzi Elena Manara Barbara Buldini Valzerda Beqiri Valeria Bisio Claudia Tregnago Roberto Rondelli Riccardo Masetti Maria Caterina Putti Franca Fagioli Carmelo Rizzari Andrea Pession Franco Locatelli Giuseppe Basso |
| Abstract: | |
| Keywords: | AML molecular MRD AML1-ETO RUNX1-RUNX1T1 CBFB-MYH11 pediatric RQ-PCR AIEOP t(8 21) inv(16) |